What is Perjeta (pertuzumab) for?
Buy Perjeta (Pertuzumab). Perjeta (pertuzumab) is used to treat HER2 positive breast cancer. It helps patients with metastatic cancer or as a first step before surgery for early-stage cancer.
How does Perjeta (pertuzumab) work?
Perjeta works with other medicines to fight HER2-positive breast cancer. It’s used for patients who haven’t had other treatments yet.
It’s also used before surgery for HER2-positive breast cancer. This is for patients with early-stage or locally advanced cancer.
Is Perjeta (pertuzumab) approved?
Yes, Perjeta is approved for HER2 positive breast cancer. It was approved by:
- FDA (USA) on June 12, 2012
- EMA (EU) on March 4, 2013
- TGA (AUS) on May 6, 2013
- Health Canada on May 8, 2013
- Medsafe (New Zealand) on July 18, 2013
How do I take Perjeta (pertuzumab)?
The usual dose is:
- First dose: 840 mg as a 60-minute IV infusion
- Next doses: 420 mg as a 30 to 60-minute IV infusion every 3 weeks.
For metastatic breast cancer, keep taking Perjeta and trastuzumab until the disease gets worse or side effects are too much.
In neoadjuvant treatment, get Perjeta every 3 weeks for 3 to 6 cycles before surgery.
For more details on dosage and how to take Perjeta, see the references section.
Note: Always talk to your doctor about your specific treatment plan.
Common side effects of Perjeta (pertuzumab)
Common side effects with Perjeta and chemotherapy include:
- diarrhoea
- alopecia (hair loss)
- nausea
- neutropenia (low neutrophils, important for fighting infections).
Serious side effects of Perjeta (pertuzumab)
Common serious side effects are:
- febrile neutropenia (low neutrophils with fever)
- serious diarrhoea
- leucopenia (low white blood cell counts)
- neutropenia.